REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 166 filers reported holding REGENXBIO INC in Q3 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $510,719 | -32.5% | 30,582 | -18.4% | 0.00% | 0.0% |
| Q2 2023 | $756,539 | +30.8% | 37,471 | +20.6% | 0.00% | 0.0% |
| Q1 2023 | $578,399 | +57.2% | 31,080 | +88.4% | 0.00% | – |
| Q4 2022 | $367,840 | +12.1% | 16,495 | +35.0% | 0.00% | -100.0% |
| Q3 2022 | $328,000 | +56.2% | 12,219 | +45.4% | 0.00% | – |
| Q2 2022 | $210,000 | -34.6% | 8,406 | -11.8% | 0.00% | – |
| Q1 2022 | $321,000 | +4.2% | 9,533 | +22.4% | 0.00% | – |
| Q2 2021 | $308,000 | -35.8% | 7,788 | -44.6% | 0.00% | -100.0% |
| Q1 2021 | $480,000 | -70.8% | 14,063 | -68.5% | 0.00% | -66.7% |
| Q2 2020 | $1,642,000 | +656.7% | 44,578 | +743.8% | 0.00% | – |
| Q4 2019 | $217,000 | -13.2% | 5,283 | -24.8% | 0.00% | – |
| Q3 2019 | $250,000 | -20.9% | 7,021 | +14.4% | 0.00% | -100.0% |
| Q2 2019 | $316,000 | +3.9% | 6,138 | +15.6% | 0.00% | 0.0% |
| Q1 2019 | $304,000 | – | 5,309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |